Teva Pharmaceutical Industries Ltd Adr (TEVA)

03:08 AM

symbol__ Stock Quote Price and Forecast - CNN

03:08 AM

12:30 PM

[Latest] Global Generic Drug Market Size/Share Worth USD 926.54 Billion by 2034 at a 6.55% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire Inc.

12:30 PM

Jun 05, 2026

TEVA Stock Price, Quote & Chart | TEVA PHARMACEUTICAL-SP ADR (NYSE:TEVA) - ChartMill

Jun 05, 2026

Jun 04, 2026

How Investors May Respond To Teva (TEVA) Pivoting From Generics Toward Higher-Margin Branded Therapies - Sahm

Jun 04, 2026

Jun 03, 2026

TEVA News | TEVA PHARMACEUTICAL-SP ADR (NYSE:TEVA) - ChartMill

Jun 03, 2026

Jun 01, 2026

Teva to Present at the Goldman Sachs Global Healthcare Conference - Sahm

Jun 01, 2026

May 31, 2026

Assessing Teva (NYSE:TEVA) Valuation After New IMPACT-TD Registry Findings On Tardive Dyskinesia - Sahm

May 31, 2026

May 30, 2026

TEVA PHARMACEUTICAL-SP ADR (NYSE:TEVA) Flags Technical Breakout Setup with Top Ratings - ChartMill

May 30, 2026

May 29, 2026

Teva- Pharmaceutical Industries Ltd.ADR (TEVA) News, Articles, Events & Latest Updates - Stocktwits

May 29, 2026

May 27, 2026

Updating Moat and Valuation for Teva to Reflect Improved Outlook - Morningstar

May 27, 2026

May 27, 2026

Teva: Upgrading Moat and Raising Valuation on Portfolio Improvements and Deep Pipeline - Morningstar

May 27, 2026

May 25, 2026

Here's How Much $100 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth Today - Sahm

May 25, 2026

May 24, 2026

A Look At Teva (NYSE:TEVA) Valuation After EMA Accepts Filing For Monthly Schizophrenia Injection - Sahm

May 24, 2026

May 23, 2026

Teva Pharmaceutical Industries Limited Sponsored ADR Trade Ideas — LSX:883035 - TradingView

May 23, 2026

May 23, 2026

Will Teva’s New TD Data on Young Adults Shift Its Neuroscience-Focused Investment Narrative (TEVA)? - Sahm

May 23, 2026

May 20, 2026

Teva Pharmaceutical’s SWOT analysis: stock navigates growth reset - Investing.com

May 20, 2026

May 20, 2026

Teva Shares Rise Following Launch of First Generic GLP-1 Weight Loss Drug - MSN

May 20, 2026

May 19, 2026

TEVA Stock Chart | TEVA PHARMACEUTICAL-SP ADR (NYSE:TEVA) - ChartMill

May 19, 2026

May 17, 2026

A Look At Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After A Strong Year And Recent Pullback - Sahm

May 17, 2026

May 15, 2026

Earnings call transcript: Teva Q1 2026 earnings beat forecasts - Investing.com

May 15, 2026

May 15, 2026

Earnings call transcript: Teva Q1 2026 earnings beat forecasts By Investing.com - Investing.com Canada

May 15, 2026

May 13, 2026

How Investors May Respond To Teva (TEVA) Showcasing CNS Growth And Emalex Deal At Key Conferences - Sahm

May 13, 2026

May 12, 2026

Earnings call transcript: Teva beats Q1 2026 expectations with strong growth - Investing.com

May 12, 2026

May 12, 2026

Earnings call transcript: Teva beats Q1 2026 expectations with strong growth By Investing.com - Investing.com Australia

May 12, 2026

May 10, 2026

TEVA Stock Price Prediction 2025-2026 | Teva Pharma Industries Ltd ADR Forecast - 24/7 Wall St.

May 10, 2026

May 08, 2026

A Look At Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After Strong Q1 2026 And Biopharma Pipeline Progress - Sahm

May 08, 2026

May 06, 2026

Is It Too Late To Reassess Teva Pharmaceutical Industries (TEVA) After Its Strong Multi Year Rally? - Sahm

May 06, 2026

May 05, 2026

Reddit Upgraded, Spotify Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

May 05, 2026

May 03, 2026

Why Teva (TEVA) Is Up 14.1% After Strong Q1 Profitability And Neuroscience Pivot News - Sahm

May 03, 2026

May 01, 2026

Teva Pharmaceutical (TEVA) Q1 EPS Of US$0.32 Tests Bullish Profitability Narrative - Sahm

May 01, 2026

Apr 30, 2026

Teva Signals Confidence With $700 Million Pipeline Push, Buyback Plan - Sahm

Apr 30, 2026

Apr 30, 2026

Teva Pharmaceutical Indus Q1 2026 Earnings Call Transcript - Sahm

Apr 30, 2026

Apr 30, 2026

Teva’s 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond Targets - Sahm

Apr 30, 2026

Apr 29, 2026

Teva’s Home Ground Schizophrenia Push And What It Could Mean For Investors - Sahm

Apr 29, 2026

Apr 29, 2026

Teva Enjoys Strong Start to 2026 Thanks to Strong Momentum in Branded Portfolio - Morningstar

Apr 29, 2026

Apr 29, 2026

Earnings call transcript: Teva beats Q1 2026 forecasts, stock surges 7.5% - Investing.com

Apr 29, 2026

Apr 27, 2026

Intel Upgraded, Toyota Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Apr 27, 2026

Apr 23, 2026

Dermatomycoses Market Report 2025-2035, Profiles of Prominent Players - GlobeNewswire Inc.

Apr 23, 2026

Apr 22, 2026

Is It Too Late To Reassess Teva (TEVA) After Its 118.5% One-Year Surge? - Sahm

Apr 22, 2026

Apr 19, 2026

Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After The Home Ground Schizophrenia Platform Launch - Sahm

Apr 19, 2026

Apr 16, 2026

Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners - Sahm

Apr 16, 2026

Apr 14, 2026

Teva Pharmaceutical (ADR) stock (US88162G1031): Why generic drug execution is suddenly worth a close - AD HOC NEWS

Apr 14, 2026

Apr 14, 2026

Does Biosimilar Wins in Osteoporosis and Allergy Care Change The Bull Case For Teva (TEVA)? - Sahm

Apr 14, 2026

Apr 12, 2026

A Look At Teva Pharmaceutical Industries (TEVA) Valuation After Recent Biosimilar Regulatory Milestones - Sahm

Apr 12, 2026

Apr 07, 2026

Target Upgraded, Robinhood Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Apr 07, 2026